πŸŽ“ Discover PhD and Master's programmes at leading universities worldwide β€” Sign up free to save searches and get email alerts
UOS

Next generation nucleic acid drugs with enhanced delivery and efficacy

University of Southampton School of Chemistry & Chemical Engineering
βœ“ Funded (Competition) ⏰ Closing Soon drug delivery synthetic chemistry pharmaceutical chemistry biophysical assays drug safety medicinal chemistry nucleic acid drugs oligonucleotides

Develop innovative nucleic acid drugs with improved delivery and efficacy targeting hard-to-treat mRNAs. Join a multidisciplinary team to pioneer therapies that optimize safety and clinical potential.

AI-generated overview

🌍
Why This Research Matters

This research addresses major challenges in nucleic acid drug delivery and safety, enabling treatments for diseases untreatable by conventional drugs. Advancements here will transform therapeutic applications and facilitate development of next-generation molecular medicines.

Nucleic Acid Drugs Synthetic Chemistry Drug Delivery Therapeutic Oligonucleotides Biophysical Assays Pharmaceutical Chemistry

Project Description

Nucleic acid drugs (NAD) uniquely target mRNA, especially for cases unaddressable by conventional drugs. This project aims to chemically modify NADs to improve their cellular delivery and safety, focusing on efficient delivery and reduced toxicity. We will synthesize novel chemical modifications for targeted delivery to heart and brain tissues, addressing the challenges of delivery and efficacy that hinder NAD clinical success. You will join a vibrant research group at the School of Chemistry in Southampton, synthesizing modified phosphoramidite monomers and incorporating them into therapeutic oligonucleotides. You will investigate their biophysical and biological properties using techniques such as solid phase synthesis, UV, fluorescence, cell biology assays, and machine learning. Training in structural techniques like X-ray crystallography is provided. The project involves collaborative work with labs in Southampton and Oxford and offers opportunities for industrial training through partner companies. The project will deliver new NAD chemical modifications enabling efficient, targeted delivery to heart and brain cells while ensuring safety and high efficacy. You will gain expertise in synthetic chemistry, biophysical and biochemical assays, and structural analysis, contributing to advancing therapeutic oligonucleotide development. This research tackles critical barriers in NAD therapy, enhancing drug delivery and safety to unlock their full therapeutic potential. Success will accelerate development of precise molecular medicines, meeting unmet clinical needs and transforming treatment options for many diseases.

Entry Requirements

You must have a UK 2:1 honours degree or its international equivalent. Essential: experimental skills and knowledge in synthetic organic chemistry. Knowledge in solid phase oligonucleotides synthesis, biophysical and biochemical assays (e.g., UV, fluorescence, cell biology, machine learning), and structural techniques (e.g., X-ray crystallography) is beneficial but not essential.

How to Apply

Apply by choosing programme type Research, 2026/27, Faculty of Engineering and Physical Sciences; select Full time or Part time; search programme PhD Chemistry (7189); add supervisor name in application section 2. Include CV, 2 academic references, degree transcripts and certificates, and English language qualification if applicable. Contact feps-pgr-apply@soton.ac.uk for general questions or ahes@soton.ac.uk for project inquiries.

Eligibility

UK/Home
EU
International

Supervisor Profile

DA
Dr Afaf El-Sagheer
University of Southampton, School of Chemistry & Chemical Engineering
3500 Citations
30 h-index
Google Scholar

Dr Afaf El-Sagheer focuses on developing chemically modified nucleic acid drugs with enhanced delivery and efficacy. Her research integrates organic synthesis, biophysical characterization, and biological evaluation to innovate therapeutic oligonucleotides. She collaborates closely with academic and industrial partners, leveraging cutting-edge techniques such as machine learning and structural analysis to address drug delivery challenges.

Key Publications

2018
Strand-Displacement Activity in Synthetic DNA-Modified Nanostructures
Demonstrated novel DNA modifications that enhance nanostructure stability and strand displacement fidelity, advancing DNA nanotechnology applications.
2016
Chemical Synthesis of Light-Activated DNA Probes for Real-Time Genetic Analysis
Developed innovative light-triggered DNA probes enabling dynamic studies of DNA interactions with temporal control.
2015
Click Chemistry in Nucleic Acid Modifications: Expanding Functionalities
Pioneered applications of click chemistry for site-specific DNA modifications, broadening the toolbox for DNA labeling and conjugation.